Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting FBRT Q1 2026 Earnings Significant EPS Miss Amidst Challenging Market Conditions Fidelity D D Bancorp FDBC Q4 2025 Earnings Solid EPS of 137 Amid Quiet Market Reaction Clean Harbors CLH Q1 2026 Earnings EPS Beats Estimates Stock Rises Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status BAH Q1 2026 Earnings Strong EPS Beat Drives Share Gains